Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22018301 | 0.86 | HDAC4 (0.39) | LMNARAB9AHPGDALDH1A1MEN1 | |
| SCHEMBL22018320 | 0.83 | HPGD (0.46) | LMNARAB9ANPC1HPGDALDH1A1 | |
| SCHEMBL22336364 | 0.82 | CA2 (0.40) | CA2CA1HPGDMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL22322614 | 0.81 | CA2 (0.39) | LMNACA2CA1HPGDCA12 | |
| SCHEMBL22322613 | 0.80 | LMNA (0.35) | LMNACA2CA1HPGDHTT | |
| SCHEMBL22018100 | 0.79 | KDM4E (0.32) | LMNACA2CA1HPGDKDM4E | |
| SCHEMBL22322562 | 0.79 | NPC1 (0.38) | LMNACA2CA1RAB9ANPC1 | |
| SCHEMBL22017885 | 0.79 | CA1 (0.38) | CA2CA1HPGDALDH1A1KDM4E | |
| SCHEMBL22018297 | 0.78 | BAZ2B (0.39) | CA2HPGDHTTSMN1; SMN2KDM4E | |
| SCHEMBL22018099 | 0.75 | MAPK1 (0.35) | LMNAHPGDMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210403435-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2021-12-30 | — | — | US | disclosed |
| WO-2020099367-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210403435-A1 | HERBICIDAL COMPOUNDS | DDT, CYP4X1, CYP1B1 | LMNA 3801/4885CA2 605/4885CA1 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.